Assaf Moore

11PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapyPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 31, 2025
BRAF inhibitor or BRAF/MEK inhibitor treatment for patients with metastatic BRAF V600E mutated differentiated thyroid cancer.

Inbar Finkel, Yasmin Korzets, Assaf Moore

|Sep 02, 2020
Efficacy of immune-checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta-analysis.

Yulia Kundel, Michal Sternschuss, Assaf Moore

|Jul 17, 2020
Induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancer: Single institution experience.

Or Dagan, Assaf Moore, Yuval Nachalon

|Jun 07, 2020
The effect of radiotherapy on taste sensation in head and neck cancer patients - a prospective study.

Michal Asif, Assaf Moore, Noam Yarom

|May 07, 2020
The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real-world early-stage breast cancer.

Daniel A Goldstein, Chen Mayer, Tzippy Shochat

|Jan 16, 2020
Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?

Assaf Moore, Elad Hikri, Tal Goshen-Lago

Pageof 2

Frequent Collaborators

2 joint publications

Daniel A Goldstein

2 joint publications

Hadar Goldvaser

1 joint publications

Michal Sarfaty

1 joint publications

Or Dagan